1. Home
  2. AKR vs TVTX Comparison

AKR vs TVTX Comparison

Compare AKR & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acadia Realty Trust

AKR

Acadia Realty Trust

HOLD

Current Price

$20.15

Market Cap

2.7B

Sector

Real Estate

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$34.72

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKR
TVTX
Founded
1993
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.1B
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
AKR
TVTX
Price
$20.15
$34.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
15
Target Price
$22.00
$37.21
AVG Volume (30 Days)
1.1M
1.4M
Earning Date
10-28-2025
10-30-2025
Dividend Yield
4.03%
N/A
EPS Growth
18.54
N/A
EPS
0.12
N/A
Revenue
$389,489,000.00
$435,826,000.00
Revenue This Year
N/A
$120.36
Revenue Next Year
$16.18
$37.33
P/E Ratio
$160.61
N/A
Revenue Growth
6.01
114.22
52 Week Low
$16.98
$12.91
52 Week High
$25.83
$37.50

Technical Indicators

Market Signals
Indicator
AKR
TVTX
Relative Strength Index (RSI) 54.02 54.24
Support Level $19.79 $33.84
Resistance Level $20.46 $35.97
Average True Range (ATR) 0.43 1.45
MACD -0.01 -0.33
Stochastic Oscillator 48.48 31.23

Price Performance

Historical Comparison
AKR
TVTX

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: Core Portfolio segment consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds primarily retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: